1488.7000 -6.10 (-0.41%)
NSE May 29, 2025 12:02 PM
Volume: 76,588
 

1488.70
-0.41%
Sharekhan
Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended